January 13, 2026- ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator (WCD) saved 143 patients between Thanksgiving Day (U.S.) and New Year’s Day, an average of four patients per day. LifeVest is a wearable cardioverter defibrillator (WCD) that is prescribed to heart patients who are at temporary risk of sudden cardiac death due to certain rapid life-threatening heart rhythms. When needed, the device can deliver a lifesaving treatment shock.
More clinicians and patients are choosing a LifeVest WCD today than ever before. LifeVest ranks #1 in patient compliance this decade at 23.4+ hours/day (median) based on peer-reviewed publications and real-world data. ZOLL completed full U.S. launch of a next generation LifeVest garment prior to the 2025 holiday season. Patients prefer the next generation garment as even more comfortable and easier to use.